🔎 Trials Near Me

Hjem › Overvekt › North Carolina › Havelock

Kliniske studier for Overvekt i Havelock, NC

17 studier for Overvekt søker deltakere på steder i og rundt Havelock (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RekruttererFase 3
  • West Clinical Research, Morehead City · 15 mi unna
Alder 18 til 99 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • West Clinical Research, Morehead City · 15 mi unna
Alder 45 til 99 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Centricity Research - Morehead city /ID# 283264, Morehead City · 15 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07752979

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RekruttererFase 3
  • West Clinical Research, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • Lucas Research, Inc, Morehead City · 15 mi unna
Alder 6 til 17 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RekruttererFase 3
  • Carteret Medical Group, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • West Clinical Research, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Lucas Research, Inc, Morehead City · 15 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 3
  • AURORA-1 Clinical Site, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • Centricity Research Morehead City Multispeciality, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RekruttererFase 2
  • Lucas Research, Inc., Morehead City · 15 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RekruttererFase 3Frivillige helsepersonell ønskes velkommen
  • ACCOMPLISH-2 Research Site, Morehead City · 15 mi unna
Alder 18 til 79 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Lucas Research, Inc, Morehead City · 15 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Morehead City · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284875

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RekruttererFase 3
  • Centricity Research Morehead City Specialty, Morehead City · 15 mi unna
Alder 18 til 99 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07575399

Overvekt-studier i andre byer

Andre studier i Havelock

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.